Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction
Launched by EDUARDO VARGAS-BAQUERO · May 26, 2017
Trial Information
Current as of May 19, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Spinal cord injury
- • Erectile dysfunction
- • No Medical Contraindication to use Avanafil and/or Sildenafil
- • Able to provide informed consent
- • Able to complete questionnaires
- Exclusion Criteria:
- • Medical Contraindication to use Avanafil and/or Sildenafil
- • No spinal cord injury
- • Congenital spinal cord injury
- • Not able to provide informed consent
- • Not able to complete questionnaires
About Eduardo Vargas Baquero
Eduardo Vargas-Baquero is a dedicated clinical trial sponsor committed to advancing medical research through innovative and rigorous study designs. With a strong background in clinical medicine and research methodology, he focuses on developing and overseeing clinical trials that prioritize patient safety and efficacy of treatments. His leadership emphasizes collaboration with multidisciplinary teams, adherence to regulatory standards, and the integration of cutting-edge technologies to improve patient outcomes. Through his efforts, Vargas-Baquero aims to contribute significantly to the field of clinical research, fostering advancements that enhance health care and therapeutic options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toledo, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials